ClinicalTrials.Veeva

Menu

Evaluation on Visual Outcome of TMS

E

Evidence Based Cataract Study Group

Status

Not yet enrolling

Conditions

Visual Impairment

Treatments

Procedure: Control
Procedure: TMS

Study type

Interventional

Funder types

Other

Identifiers

NCT06612190
EBCSG2024015

Details and patient eligibility

About

The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients with visual impairment. The main question it aims to answer is:

• Does TMS improve the visual outcome in patients who suffer from visual impairment? Researchers will compare TMS to the control group who will not receive effective TMS treatment) to see if TMS works to improve the visual outcomes of the patients.

Participants will

  • Undergo TMS treatment or no effective TMS for consecutive 5 days.
  • Visit the clinic once every 2 weeks for checkups and tests.

Enrollment

300 estimated patients

Sex

All

Ages

6 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Post cataract surgery or clear lens
  • Best-corrected visual acuity less than 0.1logMAR

Exclusion criteria

  • Diagnosed with cognitive impairment or mental disorders and unable to cooperate with treatment;
  • Diagnosed with ocular diseases that affect observation of visual function;
  • History of epileptic seizures;
  • Long term use of psychotropic drugs;
  • Metal implants in the body.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

300 participants in 2 patient groups

TMS
Experimental group
Treatment:
Procedure: TMS
Control
Sham Comparator group
Treatment:
Procedure: Control

Trial contacts and locations

1

Loading...

Central trial contact

Xiangjia Zhu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems